Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Efficacy or effectiveness?

December 9, 2008 Research and Development Les Rose, clinical trials, evidence

The question of ‘generalisability’ – or the extent clinical trials can be applied to the real world, has been an …
Feature

Caution: you are entering phase III

December 8, 2008 Research and Development clinical trials, drug development, phase III

Patient: "I've just gone into phase III! What are my chances of coming through alive?" Doctor: "Well the prognosis is …
Feature

Pharma input vital to UK research vision

November 21, 2008 Research and Development reg

Initiatives to make the UK a world class location for medical research needs significant pharma input to be a success, …
News

Pfizer makes major stem cell investment

November 19, 2008 Research and Development Pfizer, regenerative medicine, stem cell

Pfizer has launched a global stem cell research unit to develop a new generation of medicines.The research unit, to be …
News

Targeted cancer drugs boost success rates

November 18, 2008 Research and Development

Targeted cancer drugs like Herceptin and Glivec have greatly improved pharma's oncology pipeline success rates, according to a new study. …
News

Good Publication Practice 2: updating best practice

November 13, 2008 Research and Development, Sales and Marketing GPP, Good Publication Practice, clinical trials, ethics, journals, publication

 Results from clinical trials are the very lifeblood of the pharmaceutical industry, representing the frontline in the search for new …
Feature

MedImmune broadens drug discovery in Cambridge

November 13, 2008 Research and Development Cambridge, MedImmune

MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
News

Amgen talks up blockbuster prospects

November 12, 2008 Research and Development, Sales and Marketing Amgen

Amgen says two of its pipeline products are potential blockbusters in three indications. The company is keen to reaffirm its …
News

Patheon opens European headquarters in Switzerland

November 11, 2008 Research and Development Patheon

Contract research organisation Patheon has opened a new European head office in Zug, Switzerland, near Zurich. The new headquarters will …
News

Working Life: Viggo Birch

November 10, 2008 Business Services, Research and Development, Sales and Marketing Novo Nordisk, WL, careers

How did you arrive at your current position?A long story. I started in Mobil Oil in Denmark after graduating from …
Feature

Latest news from Datamonitor

November 10, 2008 Research and Development, Sales and Marketing HRT

Is there an alternative to HRT for menopausal relief?Sales of hormone replacement therapy have declined recently due to safety concerns, …
News

Study boost for Roche’s Actemra

October 30, 2008 Research and Development, Sales and Marketing RA, Roche

New data shows Roche's Actemra (tocilizumab) increases the disease remission rate in rheumatoid arthritis (RA) sufferers. The company says the …
News

Strong results for Novartis drug in rare autoimmune disease

October 30, 2008 Research and Development, Sales and Marketing Novartis

Novartis' development drug ACZ885 (canakinumab) has turned in impressive results in trials for rare medical conditions. It showed sustained remission …
News

Specialising for success

October 29, 2008 Research and Development, Sales and Marketing marketing, product portfolio

From the middle of the last century, the likes of GSK, Pfizer, AstraZeneca, Bristol Myers Squibb and others have made …
Feature

Working Life: Philip Sarbutt

October 28, 2008 Research and Development, Sales and Marketing UK, Wyeth, Wyeth Pharmaceuticals, outsourcing

How did you find your way into your role?
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026